| 标题 |
Profiling the immune repertoire in a phase II trial of niraparib and dostarlimab in recurrent or persistent uterine serous carcinomas |
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)